Get the Stockscreener App
3.46
4.42%
-0.16
After Hours:
3.45
-0.010
-0.29%
Sight Sciences Inc stock is traded at $3.46, with a volume of 97,070.
It is down -4.42% in the last 24 hours and down -18.59% over the past month.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
See More
Previous Close:
$3.62
Open:
$3.61
24h Volume:
97,070
Relative Volume:
0.73
Market Cap:
$181.19M
Revenue:
$81.06M
Net Income/Loss:
$-55.55M
P/E Ratio:
-3.0351
EPS:
-1.14
Net Cash Flow:
$-47.98M
1W Performance:
-6.23%
1M Performance:
-18.59%
6M Performance:
+28.62%
1Y Performance:
-47.97%
1-Day Range:
$3.45
$3.61
1-Week Range:
$3.375
$3.77
52-Week Range:
$2.03
$7.03
Sight Sciences Inc Stock (SGHT) Company Profile
Name
Sight Sciences Inc
Sector
Industry
Phone
(415) 889-0550
Address
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
3.46 | 178.57M | 81.06M | -55.55M | -47.98M | -1.14 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-25 | Upgrade | Lake Street | Hold → Buy |
| Dec-06-24 | Initiated | UBS | Buy |
| Nov-04-24 | Downgrade | Lake Street | Buy → Hold |
| Aug-21-24 | Initiated | Lake Street | Buy |
| Sep-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-12-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-12-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-10-23 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-23 | Upgrade | Stifel | Hold → Buy |
| Oct-04-22 | Initiated | Needham | Hold |
| Jul-26-22 | Initiated | Stifel | Hold |
| Feb-03-22 | Initiated | William Blair | Outperform |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
View All
Sight Sciences Inc Stock (SGHT) Latest News
How to manage a losing position in Sight Sciences Inc.Entry Point & High Accuracy Swing Trade Signals - Newser
Will Sight Sciences Inc. benefit from macro trendsBuy Signal & Weekly Breakout Opportunity Watchlist - Newser
Will Sight Sciences Inc. stock recover after recent dropQuarterly Trade Summary & Long-Term Capital Growth Strategies - Newser
How to recover losses in Sight Sciences Inc. stockWall Street Watch & Fast Gaining Stock Strategy Reports - Newser
Can trapped investors hope for a rebound in Sight Sciences Inc.Earnings Beat & Low Risk Entry Point Guides - Newser
Is Sight Sciences Inc. stock bottoming outRecession Risk & Community Consensus Picks - Newser
Published on: 2025-09-12 13:55:49 - Newser
Using portfolio simulators with Sight Sciences Inc. includedQuarterly Trade Summary & Verified Short-Term Plans - Newser
Will breakout in Sight Sciences Inc. lead to full recoveryWeekly Stock Summary & Verified Entry Point Signals - Newser
Top chart patterns to watch in Sight Sciences Inc.2025 Volume Leaders & Long-Term Growth Stock Strategies - Newser
Sight Sciences (NASDAQ:SGHT) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Sight Sciences, Inc. (NASDAQ:SGHT) Receives $4.42 Consensus Price Target from Analysts - MarketBeat
Analyzing recovery setups for Sight Sciences Inc. investorsJuly 2025 EndofMonth & Reliable Price Breakout Alerts - Newser
Real time pattern detection on Sight Sciences Inc. stockJuly 2025 Selloffs & AI Driven Price Predictions - Newser
Insider Sellers Might Regret Selling Sight Sciences Shares at a Lower Price Than Current Market Value - simplywall.st
Analyzing Lucid Diagnostics (NASDAQ:LUCD) and Sight Sciences (NASDAQ:SGHT) - Defense World
Developing predictive dashboards with Sight Sciences Inc. dataRate Hike & Low Drawdown Investment Strategies - Newser
Applying sector rotation models to Sight Sciences Inc.July 2025 Breakouts & Long Hold Capital Preservation Plans - Newser
What momentum shifts mean for Sight Sciences Inc.Quarterly Profit Review & Risk Adjusted Buy and Sell Alerts - Newser
Published on: 2025-09-10 00:19:16 - Newser
How to escape a deep drawdown in Sight Sciences Inc.July 2025 Market Mood & Daily Oversold Stock Bounce Ideas - Newser
How to use Fibonacci retracement on Sight Sciences Inc.Share Buyback & Low Drawdown Momentum Ideas - Newser
UnitedHealthcare to cover OMNI glaucoma procedure starting October By Investing.com - Investing.com South Africa
UnitedHealthcare Adds Sight Sciences OMNI System To Covered Glaucoma Surgery Procedures - AOL.com
UnitedHealthcare to cover OMNI glaucoma procedure starting October - Investing.com
Sight Sciences Says Omni Surgical System Gains UnitedHealthcare Coverage - MarketScreener
Sight Sciences Announces UnitedHealthcare Coverage for Innovative Glaucoma Treatments Effective October 2025 - Quiver Quantitative
Sight Sciences Announces the OMNI® Surgical System to be - GlobeNewswire
30 Million UnitedHealthcare Members Gain Access: Sight Sciences' OMNI System Approved for Glaucoma Treatment - Stock Titan
Institutional Tools Highlight Unusual Flow in Sight Sciences Inc.2025 Retail Activity & Expert Curated Trade Ideas - beatles.ru
Sight Sciences Announces Workforce Reduction Plan - MSN
Can volume confirm reversal in Sight Sciences Inc.Weekly Gains Summary & Technical Analysis for Trade Confirmation - Newser
Using R and stats models for Sight Sciences Inc. forecasting2025 Year in Review & Fast Moving Stock Trade Plans - Newser
Strategies to average down on Sight Sciences Inc.July 2025 PostEarnings & Precise Buy Zone Identification - Newser
Will Sight Sciences Inc. outperform tech stocksMarket Performance Recap & High Conviction Investment Ideas - beatles.ru
Sight Sciences Inc Stock (SGHT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):